Theravance Biopharma (TBPH) Divestments (2020 - 2022)
Theravance Biopharma's (TBPH) quarterly Divestments came in at -$1.1 billion in Q4 2022, down 7416.0% on a QoQ basis from $14.9 million in Q1 2020.
Theravance Biopharma (TBPH) Divestments (2020 - 2022) Analysis & Trends
Theravance Biopharma (TBPH) has 2 years of Divestments data on file, last reported at -$1.1 billion in Q4 2022.
- On a quarterly basis, Divestments changed N/A year-over-year to -$1.1 billion in Q4 2022; TTM through Dec 2022 was -$1.1 billion, a N/A change from a year earlier, with the FY2022 full-year figure at $2.7 million, changed N/A from the prior year.
- Divestments for Q4 2022 stood at -$1.1 billion, down from $14.9 million in the prior quarter.
- Over the last five years, Divestments for TBPH reached as high as $14.9 million in Q1 2020 and fell as low as -$1.1 billion in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -1.09 Bn |
| Mar 31, 2020 | 14.93 Mn |